News & Updates
See below the latest news updates from HiTech Health
CanVas Consortium including HiTech Health receives €10.7 million DTIF grant to advance new class of cell therapy to clinic for early brain injury
Dublin, Ireland, 10th April 2025 – HiTech Health, a Contract Development and Manufacturing Organisation (CDMO) specialising in advanced medicines, is delighted to communicate that the CanVas consortium led by HAON life sciences (a leading cell therapy biotech company)...
Investigational Medicinal Product (IMP) Importation into the EU: 3 Key Considerations for Success
If you are planning on conducting clinical trials in the EU and are importing Investigational Medicinal Products (IMPs) then there are many factors to consider prior to clinical trial initiation. An IMP refers to a medicinal product that is being tested or used in a...
Why Ireland for Manufacturing Cell and Gene Therapies?
Ireland has a strong track record of attracting major investment from the largest pharma companies in the world. The foundation of Ireland’s life sciences industry has been the small-molecule sector and has since developed expertise in biologics manufacturing. Ireland...